U.S. market Closed. Opens in 1 day 3 hours 52 minutes

RLMD | Relmada Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312019-06-302018-06-302017-06-302016-06-302015-06-302013-08-312012-08-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A5.13K7.94K
Cost of RevenueN/AN/A1.26K3.75KN/A4.87K2.63K85.27K54.82K9.26K4.04K5.80K
Gross ProfitN/AN/A-1.26K-3.75KN/A-4.87K-2.63K-85.27K-54.82K-9.26K1.09K2.14K
Operating Expenses103.70M161.25M125.70M60.84M15.11M12.73M6.92M7.22M16.22M17.10M46.11K13.82K
Selling, General & Admin48.89M47.93M35.08M24.87M7.25M5.70M3.97M5.93M10.01M9.23M46.11K13.82K
Research & Development54.81M113.32M90.62M35.97M7.86M7.02M2.94M1.29M6.21M7.87M5.38MN/A
Other Operating Expenses-293.006.35MN/AN/AN/AN/A2.35K216.21K130.27KN/AN/AN/A
Operating Income-103.70M-161.25M-125.70M-60.84M-15.11M-12.73M-6.92M-7.22M-16.22M-17.10M-45.02K-12.05K
Other Expenses / Income4.91M4.21M-48.32K1.38M104.11K-5.70M-2.04M932.31K13.24M-3.70MN/AN/A
Before Tax Income-98.79M-157.04M-125.75M-59.46M-15.01M-17.32M-8.96M-6.29M-2.97M-20.80M-45.02K-12.05K
Income Tax ExpensesN/A-2.66M48.32K-1.38M-1.004.59M2.05M-716.10K-13.11M3.70M-9.58M-377.00
Net Income-98.79M-157.04M-125.75M-59.46M-15.01M-17.32M-8.96M-6.29M-2.97M-20.80M-45.02K-12.05K
Interest ExpensesN/AN/AN/AN/AN/AN/A1.34M550.00N/A4.92KN/AN/A
Basic Shares Outstanding30.10M29.63M17.55M15.59M9.23M6.31M3.14M3.02M2.90M2.49M1.43M1.43M
Diluted Shares Outstanding30.10M29.63M17.55M15.59M9.23M6.31M3.14M3.02M2.90M2.49M1.43M1.43M
EBITDA4.91M-157.04M-125.75M-59.45M-15.10M-16.55M-6.91M-6.92M-16.03M-17.09M-45.02K-11.68K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-877.66%-147.02%
EBIT-98.79M-159.70M-125.70M-60.84M-15.01M-12.73M-5.58M-7.00M-16.09M-17.09M-9.63M-12.43K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-187,740.26%-156.52%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312019-06-302018-06-302017-06-302016-06-302015-06-302013-08-312012-08-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙